Morbidity and medication in a large population of individuals with Down syndrome compared to the general population

Developmental Medicine and Child Neurology

Volumn 58, Issue 3, 2016, Pages 246-254

  Alexander, Myriam ^a   Petri, Hans ^b   Ding, Yingjie ^c   Wandel, Christoph ^d   Khwaja, Omar ^e   Foskett, Nadia ^a  

^a ROCHE PRODUCTS LTD   (United Kingdom)

^b Petri Consulting Ltd   (United Kingdom)

^c Genesis Research Limited   (United States)

^d Roche Product Development   (United Kingdom)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIPARKINSON AGENT; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; INSULIN DERIVATIVE; LAXATIVE; NITRIC ACID DERIVATIVE; NOOTROPIC AGENT;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; AUTISM; CARDIOVASCULAR DISEASE; CHILD; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DATA BASE; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DOWN SYNDROME; DRUG THERAPY; EAR DISEASE; EPILEPSY; EYE DISEASE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHYROIDISM; INCIDENCE; INFANT; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEWBORN; OBESITY; POPULATION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEP DISORDER; UNITED KINGDOM; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; COMORBIDITY; DIGESTIVE SYSTEM DISEASES; ENDOCRINE SYSTEM DISEASES; GREAT BRITAIN; MENTAL DISORDERS; METABOLIC DISEASES; NERVOUS SYSTEM DISEASES; REGISTER; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COMORBIDITY; DIGESTIVE SYSTEM DISEASES; DOWN SYNDROME; DRUG PRESCRIPTIONS; ENDOCRINE SYSTEM DISEASES; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MENTAL DISORDERS; METABOLIC DISEASES; NERVOUS SYSTEM DISEASES; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84958659228     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12868     Document Type: Article

References (25)

1. Jensen KM, Bulova P. Managing the care of adults with Down's syndrome. BMJ 2014; 349: g5596.
2. Bull MJ, the Committee ON Genetics. Clinical report - health supervision for children with Down syndrome. Pediatrics 2011; 128: 393-406.
3. Wilson L. Perspectives in Prevention from the American College of Preventive Medicine. Preventive Care for Adults with Down Syndrome. Available from: http://www.medscape.org/viewarticle/715382 (accessed 10 January 2014).
4. Yam WKL, Tse PWT, Yu CM, et al. Medical issues among children and teenagers with Down syndrome in Hong Kong. Downs Syndr Res Pract 2008; 12: 138-40.
5. Van Gameren-Oosterom HB, Fekkes M, Buitendijk SE, Mohangoo AD, Bruil J, Van Wouwe JP. Development, problem behaviour, and quality of life in a population based sample of eight-year-old children with Down syndrome. PLoS ONE 2011; 6: e21879.
6. Henderson A, Lynch SA, Wilkinson S, Hunter M. Adults with Down's syndrome: the prevalence of complications and health care in the community. Br J Gen Pract 2007; 57: 50-55.
7. Fitzgerald P, Leonard H, Pikora TJ, Bourke J, Hammond G. Hospital admissions in children with Down syndrome: experience of a population-based cohort followed from birth. PLoS ONE 2013; 8: e70401.
8. Zhu JL, Hasle H, Correa A, et al. Hospitalizations among people with Down syndrome: a nationwide population-based study in Denmark. Am J Med Genet 2013; 161(part A): 650-57.
9. Schieve LA, Boulet SL, Boyle C, Rasmussen SA, Schendel D. Health of children 3 to 17 years of age with Down syndrome in the 1997-2005 national health interview survey. Pediatrics 2009; 123: e253-60.
10. Maas A, Didden R, Korzilius H, Curfs L. Exploration of differences in types of sleep disturbances and severity of sleep problems between individuals with Cri du Chat syndrome, Down's syndrome, and Jacobson syndrome: a case-control study. Res Dev Disabil 2012; 33: 1773-79.
11. Wood L, Martinez C. The general practice research database: role in pharmacovigilance. Drug Saf 2004; 27: 871-81.
12. Williams T, van Staa T, Puri S, Eaton S. Recent advances in the utility and use of the general practice research database as an example of a UK primary care data resource. Ther Adv Drug Saf 2012; 3: 89-99.
13. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010; 69: 4-14.
14. Roizen NJ, Patterson D. Down's syndrome. Lancet 2003; 361: 1281-89.
15. Weijerman ME, van Furth AM, van der Mooren MD, et al. Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr 2010; 169: 1195-99.
16. Morrison RA, McGrath A, Davidson G, Brown JJ, Murray GD, Lever AF. Low blood pressure in Down's syndrome, a link with Alzheimer's disease? Hypertension 1996; 28: 569-75.
17. Fernhall B, Baynard T, Collier SR, et al. Catecholamine response to maximal exercise in persons with Down syndrome. Am J Cardiol 2009; 103: 724-26.
18. Shott SR, Amin R, Chini B, Heubi C, Hotze S, Akers R. Obstructive sleep apnea: should all children with Down syndrome be tested? Arch Otolaryngol Head Neck Surg 2006; 132: 432-36.
19. Coppus A, Evenhuis H, Verberne GJ, et al. Dementia and mortality in persons with Down's syndrome. J Intellect Disabil Res 2006; 50: 768-77.
20. Visser FE, Aldenkamp AP, van Huffelen AC, Kuilman M, Overweg J, van Wijk J. Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome. Am J Ment Retard 1997; 101: 400-12.
21. Brown FR 3rd, Greer MK, Aylward EH, Hunt HH. Intellectual and adaptive functioning in individuals with Down syndrome in relation to age and environmental placement. Pediatrics 1990; 85: 450.
22. Visootsak J, Sherman S. Neuropsychiatric and behavioral aspects of trisomy 21. Curr Psychiatry Rep 2007; 9: 135-40.
23. Lader M. Benzodiazepines revisited - will we ever learn? Addiction 2011; 106: 2086-109.
24. DiGuiseppi C, Hepburn S, Davis JM, et al. Screening for autism spectrum disorders in children with Down syndrome: population prevalence and screening tests characteristics. J Dev Behav Pediatr 2010; 31: 181-91.
25. Van Gameren-Oosterom HB, van Dommelen P, Schonbeck Y, Oudesluys-Murphy AM, Van Wouwe J, Buitendijk SE. Prevalence of overweight in Dutch children with Down syndrome. Pediatrics 2012; 130: 1520-26.